Cardiovascular outcomes of enzyme‐inducing anti‐seizure medications: A real‐world Asian cohort study
Epileptic Disorders · 30.09.2026
DOI: 10.1002/epd2.70430 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Epileptic Disorders, online erschienen am 30.09.2026. Verfasst von Chun-Yu Cheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Chang Gung Memorial Hospital, Chiayi, Taiwan. Die Arbeit nennt 22 Literaturangaben. Gefördert von: Chang Gung Medical Foundation.
Abstract (Originalsprache)
Objective
To determine whether enzyme‐inducing anti‐seizure medications (EIASMs) are associated with differential risks of major adverse cardiovascular events (MACE) and all‐cause mortality compared with non‐enzyme‐inducing anti‐seizure medications (NEIASMs) in adults with epilepsy.
Methods
Using the Chang Gung Research Database (2010–2019), adults with epilepsy receiving at least 28 cumulative days of anti‐seizure medication therapy within 180 days of the index date were classified as EIASMs or NEIASMs users. Stabilized inverse probability of treatment weighting (IPTW) addressed confounding by indication. Composite MACE encompassing myocardial infarction (MI), arrhythmia, heart failure, ischemic stroke, hemorrhagic stroke, and sudden cardiac death and all‐cause mortality were co‐primary endpoints evaluated using Cox proportional hazards and Fine–Gray competing risk models.
Results
Of 20 693 eligible patients, 10 571 received EIASMs and 10 122 received NEIASMs. After IPTW, all covariates were balanced (absolute standardized mean differences
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Chang Gung Memorial Hospital, Chiayi, Taiwan.
- College of Medicine, Chang Gung University, Taoyuan, Taiwan.
- Department of Neurology, Chang Gung Memorial Hospital, Chiayi, Taiwan.
- Health Information and Epidemiology Laboratory, Chang Gung Memorial Hospital, Chiayi, Taiwan.
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Jen Ai Hospital, Taichung, Taiwan.
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, New Taipei Municipal Tucheng Hospital, New Taipei City, Taiwan.
ORCID-Profile: Chun-Yu Cheng, Ting-Chung Wang, Chia-Yu Hsu, Meng-Hung Lin, Chih-Hao Chang
Förderung
- Chang Gung Medical Foundation
Zitieren
APA
Cheng, C. Y., Wang, T. C., Hsu, C. Y., Lin, M. H., Liu, C. Y., & Chang, C. H. (2026). Cardiovascular outcomes of enzyme‐inducing anti‐seizure medications: A real‐world Asian cohort study. Epileptic Disorders. https://doi.org/10.1002/epd2.70430
Vancouver
Cheng CY, Wang TC, Hsu CY, Lin MH, Liu CY, Chang CH. Cardiovascular outcomes of enzyme‐inducing anti‐seizure medications: A real‐world Asian cohort study. Epileptic Disorders. 2026. doi:10.1002/epd2.70430
BibTeX
@article{Cheng2026,
author = {Cheng, Chun-Yu and Wang, Ting-Chung and Hsu, Chia-Yu and Lin, Meng-Hung and Liu, Chia-Yen and Chang, Chih-Hao},
title = {Cardiovascular outcomes of enzyme‐inducing anti‐seizure medications: A real‐world Asian cohort study},
journal = {Epileptic Disorders},
year = {2026},
doi = {10.1002/epd2.70430}
}
EUVIMED